- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04312061
Effect of Oral Tramadol Administration Prior to IUD Insertion
March 14, 2020 updated by: Ahmed Samy aly ashour, Cairo University
Safety and Efficacy of Oral Tramadol Administration in Reducing Pain During Levonorgestrel Intrauterine Device Insertion in Adolescents and Young Women: a Randomized Controlled Trial
the aim of the study is to evaluate the safety and efficacy of oral tramadol administration in reducing pain during LNG- IUD insertion in adolescents and young women
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
108
Phase
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 25 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- nulliparous adolescents and young women requesting LNG-IUD insertion
Exclusion Criteria:
- parous women, contraindications to LNG-IUD insertion and allergy or contraindications to tramadol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: oral tramadol
oral tramadol tablet 5o mg given 1 hour before LNG-IUD insertion
|
oral tramadol tablet 5o mg given 1 hour before LNG-IUD insertion
|
|
PLACEBO_COMPARATOR: placebo
oral placebo tablet given 1 hour before LNG-IUD insertion
|
oral placebo tablet given 1 hour before LNG-IUD insertion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain during IUD insertion
Time Frame: 5 minutes
|
intensity of patient-perceived pain at time of IUD insertion, using a visual analog scale. The VAS scale is graded from 0 to 10 on a 10 cm horizontal straight line, where 'zero' corresponds to no pain at all, and '10' to the worst possible pain imaginable. |
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration of the procedure
Time Frame: 5 minutes
|
duration of IUD insertion from speculum in to speculum out in minutes
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
March 30, 2020
Primary Completion (ANTICIPATED)
July 1, 2020
Study Completion (ANTICIPATED)
July 5, 2020
Study Registration Dates
First Submitted
March 14, 2020
First Submitted That Met QC Criteria
March 14, 2020
First Posted (ACTUAL)
March 18, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 18, 2020
Last Update Submitted That Met QC Criteria
March 14, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- tramadol IUD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Montefiore Medical CenterSociety of Family PlanningCompletedContraception | Breastfeeding | Postpartum ContraceptionUnited States
Clinical Trials on oral tramadol
-
Unither Pharmaceuticals, FranceInternational Pharmaceutical Research CenterCompleted
-
Cairo UniversityUnknown
-
University of Southern CaliforniaWithdrawnOveractive Bladder | Xerostomia | Compliance
-
Queen Elizabeth Hospital, Hong KongCompleted
-
Federal Teaching Hospital AbakalikiCompletedLabour DurationNigeria
-
University of MonastirCompleted
-
CrystalGenomics, Inc.Completed
-
Menarini GroupCompletedAcute PainRomania, Poland, Hungary, Latvia, Lithuania, Russian Federation, Slovakia, Spain
-
Alfarabi CollegesCompletedSymptomatic Irreversible PulpitisSaudi Arabia